Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy.
Effect of comorbidity on mortality in multiple sclerosis.
Headache in multiple sclerosis and autoimmune disorders.
Sunlight and Vitamin D: Necessary for Public Health.
Propentofylline treatment on open field behavior in rats with focal ethidium bromide-induced demyelination in the ventral surface of the brainstem.
Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies.
Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.
The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.
Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase.
IL-17F but not IL-17A gene polymorphism confers risk to multiple sclerosis in a Chinese Han population.
Recognising and diagnosing inflammatory brain disease.
Comorbidities at multiple sclerosis diagnosis.
Inhibition of Endogenous Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis by Inducing Myeloid-Derived Suppressor Cells.
New immunological approaches in treating and diagnosing CNS diseases.
Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
People with Multiple Sclerosis use many fall prevention strategies but still fall frequently.
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?
Association of smoking with risk of multiple sclerosis: a population-based study.
Oligodendroglia and neurotrophic factors in neurodegeneration.
AMP-Activated Protein Kinase Signaling Protects Oligodendrocytes that Restore Central Nervous System Functions in an Experimental Autoimmune Encephalomyelitis Model.
Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
Natalizumab treatment for multiple sclerosis.
Pages
« first
‹ previous
…
449
450
451
452
453
454
455
456
457
…
next ›
last »